0001209191-15-040812.txt : 20150508
0001209191-15-040812.hdr.sgml : 20150508
20150508200023
ACCESSION NUMBER: 0001209191-15-040812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150507
FILED AS OF DATE: 20150508
DATE AS OF CHANGE: 20150508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001386858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611512713
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-745-7802
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scharschmidt Bruce Frederick
CENTRAL INDEX KEY: 0001554402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 15848559
MAIL ADDRESS:
STREET 1: C/O HYPERION THERAPEUTICS, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-07
1
0001386858
HYPERION THERAPEUTICS INC
HPTX
0001554402
Scharschmidt Bruce Frederick
C/O HYPERION THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
0
1
0
0
SVP & Chief Medical Officer
Common Stock
2015-05-07
4
U
0
97471
46.00
D
0
D
Common Stock
2015-05-07
4
U
0
24448
46.00
D
0
I
By The Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001
Common Stock
2015-05-07
4
D
0
18050
46.00
D
0
D
Common Stock
2015-05-07
4
D
0
6975
46.00
D
0
D
Stock Option (Right to Buy)
7.31
2015-05-07
4
D
0
25227
46.00
D
2022-04-15
Common Stock
25227
0
D
Stock Option (Right to Buy)
24.26
2015-05-07
4
D
0
46000
46.00
D
2023-04-14
Common Stock
46000
0
D
Stock Option (Right to Buy)
26.74
2015-05-07
4
D
0
32000
46.00
D
2024-03-10
Common Stock
32000
0
D
Stock Option (Right to Buy)
25.97
2015-05-07
4
D
0
24000
46.00
D
2025-02-09
Common Stock
24000
0
D
Stock Option (Right to Buy)
327.95
2015-05-07
4
D
0
191
0.00
D
2018-03-31
Common Stock
191
0
D
Stock Option (Right to Buy)
327.95
2015-05-07
4
D
0
27
0.00
D
2018-04-21
Common Stock
27
0
D
Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
Shares that are being acquired by Horizon in the Merger.
Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.
/s/ Sally Brammell, Attorney-in-Fact
2015-05-08